Most Favoured Nations

Market Access

A dynamic moment for pharma pricing: Insights from PPIC

At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.

News

In brief SOTU remarks, Trump asks Congress to "codify" MFN

In a speech at least nominally focused on the economy and affordability, President Trump put surprisingly little emphasis on his drug pricing efforts.

Market Access

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...

Unpack the impact of Most-Favoured Nations in GLOBE and GUARD pricing models, and TrumpRx, with Alice Valder Curran's clear policy overview.

Market Access

pharmaphorum podcast Episode 141, Alice Valder Curran

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.

A dynamic moment for pharma pricing: Insights from PPIC

In brief SOTU remarks, Trump asks Congress to "codify" MFN

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al...

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

Most Favoured Nations

Editor's Picks